3SBio, Inc. (TRSBF)
3SBio Market Cap: 8.304B for Jan. 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| China Pharma Holdings, Inc. | 4.143M |
| CASI Pharmaceuticals, Inc. | 21.37M |
| Zai Lab Ltd. | 2.085B |
| Adagene, Inc. | 90.45M |
Market Cap Related Metrics
| PS Ratio | 6.927 |
| PEG Ratio | 1.298 |
| Price to Book Value | 55.26 |
| Price to Free Cash Flow | 22.94 |
| Price | 3.52 |
| Earnings Yield | 3.76% |
| PEGY Ratio | 1.243 |
| Operating PE Ratio | 26.34 |
| Normalized PE Ratio | 26.57 |